Substantially elevated levels of atorvastatin and metabolites in cyclosporine-treated renal transplant recipients

Clin Pharmacol Ther. 2004 Oct;76(4):388-91. doi: 10.1016/j.clpt.2004.07.008.
No abstract available

Publication types

  • Clinical Trial
  • Controlled Clinical Trial
  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Adult
  • Anticholesteremic Agents / chemistry
  • Anticholesteremic Agents / pharmacokinetics*
  • Area Under Curve
  • Atorvastatin
  • Chromatography, High Pressure Liquid
  • Cyclosporine / pharmacology*
  • Drug Interactions
  • Female
  • Heptanoic Acids / chemistry
  • Heptanoic Acids / pharmacokinetics*
  • Humans
  • Immunosuppressive Agents / pharmacology*
  • Kidney Transplantation*
  • Male
  • Mass Spectrometry
  • Middle Aged
  • Pyrroles / chemistry
  • Pyrroles / pharmacokinetics*

Substances

  • Anticholesteremic Agents
  • Heptanoic Acids
  • Immunosuppressive Agents
  • Pyrroles
  • Cyclosporine
  • Atorvastatin